Growth Metrics

bioAffinity Technologies (BIAF) Total Debt (2022 - 2025)

Historic Total Debt for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $43658.0.

  • bioAffinity Technologies' Total Debt rose 10138.38% to $43658.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $43658.0, marking a year-over-year increase of 10138.38%. This contributed to the annual value of $20180.0 for FY2024, which is N/A changed from last year.
  • Per bioAffinity Technologies' latest filing, its Total Debt stood at $43658.0 for Q3 2025, which was up 10138.38% from $45952.0 recorded in Q2 2025.
  • bioAffinity Technologies' 5-year Total Debt high stood at $500000.0 for Q3 2022, and its period low was $20180.0 during Q4 2024.
  • Moreover, its 4-year median value for Total Debt was $43658.0 (2025), whereas its average is $107994.4.
  • Per our database at Business Quant, bioAffinity Technologies' Total Debt plummeted by 8632.25% in 2024 and then skyrocketed by 10903.76% in 2025.
  • bioAffinity Technologies' Total Debt (Quarter) stood at $251746.0 in 2022, then plummeted by 83.18% to $42334.0 in 2023, then plummeted by 52.33% to $20180.0 in 2024, then soared by 116.34% to $43658.0 in 2025.
  • Its last three reported values are $43658.0 in Q3 2025, $45952.0 for Q2 2025, and $48156.0 during Q1 2025.